PreveCeutical Medical strikes deal with Asterion Cannabis for medical CBD

Stephen Van Deventer, chairman and CEO of PreveCeutical Medical Inc (CNSX:PREV), discusses with Proactive’s Andrew Scott the deal they’ve struck with private firm Asterion Cannabis Inc to develop medical CBD (cannabidiol) products.

In the companies’ sights via the joint venture are tablets, transdermal patches and other jointly evaluated products aimed at treating chronic pain, inflammation, epilepsy, anxiety disorders and others.


Leave a Reply

Your email address will not be published. Required fields are marked *